医学
肠促胰岛素
糖尿病
重症监护医学
入射(几何)
疾病
胰高血糖素样肽-1
肾脏疾病
内科学
2型糖尿病
内分泌学
光学
物理
摘要
The number of persons with diabetes is projected to grow from 463 million to 700 million worldwide between 2019 and 2045, with the greatest effect occurring in low- and middle-income countries.1 Given the growing number of cases of diabetes (90% of which are type 2), an increased incidence of complications of diabetes, particularly cardiovascular disease and chronic kidney disease, is anticipated.2,3 The need is urgent to develop and deploy effective therapies for diabetes — especially those that reduce the risks of serious complications — across populations. The novel concept of combining a glucose-dependent insulinotropic polypeptide with a glucagon-like peptide-1 (GLP-1) . . .
科研通智能强力驱动
Strongly Powered by AbleSci AI